Evidence map›Paper›PMID 33167567›Full record

ArticleJournal of clinical medicine2020

Current Challenges in the Post-Transplant Care of Liver Transplant Recipients in Germany.

Kerstin Herzer, Martina Sterneck, Martin-Walter Welker, Silvio Nadalin, Gabriele Kirchner, Felix Braun, Christina Malessa, Adam Herber, Johann Pratschke, Karl Heinz Weiss and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Frequency ofCanadian liver journal · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 11 institutions in 1 country.

Kerstin HerzerDepartment of Gastroenterology and Hepatology, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany.
Martina SterneckDepartment of Medicine, University Medical Center Hamburg Eppendorf, 20251 Hamburg, Germany.
Martin-Walter WelkerDepartment of Internal Medicine I, University Hospital Frankfurt, 60590 Frankfurt am Main, Germany.
Silvio NadalinDepartment for General, Visceral and Transplant Surgery, University Hospital Tuebingen, 72016 Tuebingen, Germany.
Gabriele KirchnerDepartment of Surgery, University Hospital of Regensburg, 93053 Regensburg, Germany.
Felix BraunDepartment for Transplantation Surgery, University Hospital Kiel, 24105 Kiel, Germany.
Christina MalessaDepartment of General, Visceral and Vascular Surgery, University Hospital Jena, 07747 Jena, Germany.
Adam HerberDepartment of Gastroenterology and Rheumatology, University Hospital Leipzig, 04103 Leipzig, Germany.
Johann PratschkeDepartment of Surgery, Campus Charité Mitte/Campus Virchow-Klinikum, Charité University Medicine Berlin, 13353 Berlin, Germany.
Karl Heinz WeissDepartment of Internal Medicine, University of Heidelberg, 69120 Heidelberg, Germany.
Elmar JaeckelIntegrated Research and Treatment Centre Transplantation (IFB-Tx), Hannover Medical School, 30625 Hannover, Germany.
Frank TackeDepartment of Hepatology & Gastroenterology, Campus Charité Mitte/Campus Virchow-Klinikum, Charité University Medicine Berlin, 13353 Berlin, Germany.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin · DECharité - Universitätsmedizin Berlin · DEGoethe University Frankfurt · DEHeidelberg University · DEJena University Hospital · DEMedizinische Hochschule Hannover · DERefonet · DEUniversität Hamburg · DEUniversity Hospital Leipzig · DEUniversity Hospital Regensburg · DEUniversity Hospital Schleswig-Holstein · DE

Funding

Chiesi Farmaceutici not applicable
6 · The paper itself

Abstract

Improving long-term patient and graft survival after liver transplantation (LT) remains a major challenge. Compared to the early phase after LT, long-term morbidity and mortality of the recipients not only depends on complications immediately related to the graft function, infections, or rejection, but also on medical factors such as de novo malignancies, metabolic disorders (e.g., new-onset diabetes, osteoporosis), psychiatric conditions (e.g., anxiety, depression), renal failure, and cardiovascular diseases. While a comprehensive post-transplant care at the LT center and the connected regional networks may improve outcome, there is currently no generally accepted standard to the post-transplant management of LT recipients in Germany. We therefore described the structure and standards of post-LT care by conducting a survey at 12 German LT centers including transplant hepatologists and surgeons. Aftercare structures and form of cost reimbursement considerably varied between LT centers across Germany. Further discussions and studies are required to define optimal structure and content of post-LT care systems, aiming at improving the long-term outcomes of LT recipients.

Indexed as

aftercare structuresGermanyliver transplantationliver transplantation centerlong-term outcomepost-liver transplantation management

Identifiers

PMID33167567
PMCPMC7694452
OpenAlexW3097803007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.